Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JM Integrated Health vs VyrarX

JM Integrated Health
Graded #427

Lower grade

vs+12.699999999999996
VyrarX
Graded #145

Higher grade

The verdict

VyrarX takes it — 68.6/100 to 55.9/100.

VyrarX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVyrarX +16
45
61
Dose & formulationVyrarX +11
53
64
Clinical oversightJM Integrated Health +5
89
84
Labs & monitoringVyrarX +19
53
72
FulfillmentVyrarX +15
56
71
Contract termsVyrarX +35
20
55
JM Integrated Health · left barVyrarX · right bar

The numbers

MetricJM Integrated HealthVyrarX
WeighScore55.9/10068.6/100
GradeCC
Scorecard rank#427#145
SemaglutideNot disclosed$179/mo (starting dose, compounded)
TirzepatideNot disclosed$329/mo (starting dose, compounded)
Coverage6 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JM Integrated Health

Graded #427 · C

Strengths

  • Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
  • Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
  • Six states clearly listed (TX, VT, NM, AZ, WA, NV)
  • Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
  • Publishes the FDA compounded-medication disclaimer

Where it loses points

  • 503A pharmacy partner not named publicly
  • Single-provider practice — enrollment is capacity-limited
  • Only six states served, vs nationwide competitors
  • Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
  • No LegitScript certification displayed
VyrarX

Graded #145 · C

Strengths

  • LegitScript certified with active seal (ID 51177727)
  • Semaglutide starting at $179/month with free shipping included
  • 1:1 direct provider messaging and personalized titration plan in every plan
  • Nutrition coaching included with the weight-loss program
  • Provider review completed within 24 hours; no insurance required

Where it loses points

  • Tirzepatide at $329/month starting is at the high end of the compounded market
  • Compounding pharmacy not named on any public page
  • No physician names or clinical leadership disclosed publicly
  • Only 47 states covered — the 3 excluded states are not named on the site
  • Labs not included in the weight-loss plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard